Magnetic Resonance Elastography Score Reflecting Hepatic Fibrosis as an Independent Predictor for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy
To evaluate whether MRE score reflecting hepatic fibrosis can predict the recurrence of HCC
within 2 years after RFA treatment
- Local recurrence/intrahepatic distant recurrence
- Multivariable analysis including several related factors to find whether MRE score is
an independent predictor of HCC recurrence even after adjusting other factors (etiology
of liver disease, size of HCC, vessel invasion, HBsAg titer, etc.)
To find the efficacy of each indicator (MRE score, non-invasive serum markers) compared to
the gold-standard histology score predicting hepatic fibrosis.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Number of patients who experienced HCC recurrence after RFA
To see whether MRE score reflecting hepatic fibrosis predicts the recurrence of HCC within 2 years after RFA treatment
within 2 years after RFA procedure
Jung-Hwan Yoon, M.D., Ph.D.
Seoul National University Hospital
South Korea: Institutional Review Board